Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: A review of recent literature

Clinical Transplantation

Volumn 23, Issue 3, 2009, Pages 305-312

  Fridell, Jonathan A ^a   Mangus, Richard S ^a   Tector, A J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Histidine tryptophan ketoglutarate; Intestinal transplantation; Kidney transplantation; Liver transplantation; Pancreas transplantation; Preservation solutions

Indexed keywords

HTK SOLUTION; UNIVERSITY OF WISCONSIN SOLUTION;

GRAFT PRESERVATION; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; INTESTINE TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

ADENOSINE; ALLOPURINOL; GLUCOSE; GLUTATHIONE; HUMANS; INSULIN; MANNITOL; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANSPLANTS;

EID: 66849115378     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00952.x     Document Type: Review

References (40)

1. Tullius SG, Filatenkow A, Horch D et al. Accumulation of crystal deposits in abdominal organs following perfusion with defrosted University of Wisconsin solutions. Am J Transplant 2002: 2: 627.
2. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980: 28: 295.
3. Blech M, Hummel G, Kallerhoff M, Ringert RH. Electrolyte equilibration of human kidneys during perfusion with HTK-solution according to Bretschneider. Urol Res 1997: 25: 331.
4. Potdar S, Malek S, Eghtesad B et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004: 18: 661.
5. Dunn TB, Del Coro C, Ferrer J et al. Risk factors for clinically significant graft pancreatitis - is it the solution? Am J Transplant 2008: 8 (Suppl. 2): 557.
6. Alonso D, Dunn TB, Rigley T et al. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: A cautionary tale. Am J Transplant 2008: 8: 1942.
7. Agarwal A, Murdock P, Pescovitz MD, Goggins WC, Milgrom ML, Fridell JA. Follow-up experience using histidine-tryptophan ketoglutarate solution in clinical pancreas transplantation. Transplant Proc 2005: 37: 3523.
8. Agarwal A, Powelson JA, Goggins WC, Milgrom ML, Fridell JA. Organ preservation with histidine-tryptophan ketogluatarate solution in clinical pancreas transplantation: An update of the Indiana University experience. Transplant Proc 2008: 40: 498.
9. Mangus RS, Fridell JA, Vianna RM et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl 2008: 14: 365.
10. Englesbe MJ, Heidt D, Sung R, Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? Transplantation 2006: 82: 580.
11. Englesbe MJ, Heidt D, Sung R Pietroski R. Does using HTK solution for cold perfusion of cadaveric kidneys save money? Transplantation 2006: 81: 1750.
12. Fridell JA, Agarwal A, Milgrom ML, Goggins WC, Murdock P, Pescovitz MD. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004: 77: 1304.
13. Groenewoud AF, Isemer FE, Stadler J, Heideche CD, Florack G, Hoelscher M. A comparison of early function between kidney grafts protected with HTK solution versus Euro-Collins solution. Transplant Proc 1989: 21 (1 Pt 2): 1243.
14. de Boer J, De Meester J, Smits JM et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999: 12: 447.
15. de Boer J, Smits JM, De Meester J et al. A randomized multicenter study on kidney preservation comparing HTK with UW. Transplant Proc 1999: 31: 2065.
16. Groenewoud AF, Buchholz B, Gubernatis F et al. First results of the multicenter study of HTK protection for kidney transplants. Transplant Proc 1990: 22: 2212.
17. Groenewoud AF, Thorogood J. A preliminary report of the HTK randomized multicenter study comparing kidney graft preservation with HTK and EuroCollins solutions. HTK Study Group. Transpl Int 1992: 5(Suppl. 1): S429.
18. Groenewoud AF, Thorogood J. Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. The HTK Study Group. Transplant Proc 1993: 25(1 Pt 2): 1582.
19. Lynch RJ, Kubus J, Chenault RH, Pelletier SJ, Campbell DA, Englesbe MJ. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin preservation in renal transplantation. Am J Transplant 2008: 8: 567.
20. Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005: 37: 2016.
21. Roels L, Coosemans W, Donck J et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 1998: 66: 1660.
22. Agarwal A, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts. Transplantation 2006: 81: 480.
23. Opelz G, Dohler B. Multicenter analysis of kidney preservation. Transplantation 2007: 83: 247.
24. Englesbe MJ, Moyer A, Kim DY et al. Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study. Transplantation 2006: 82: 136.
25. Becker T, Ringe B, Nyibata M et al. Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: Is there a difference? JOP 2007: 8: 304.
26. Gubernatis G, Dietl KH, Kemnitz J et al. Extended cold preservation time (20hours 20minutes) of a human liver graft by using cardioplegic HTK solution. Transplant Proc 1991: 23: 2408.
27. Gubernatis G, Pichlmayr R, Lamesch P et al. HTK-solution (Bretschneider) for human liver transplantation. First clinical experiences. Langenbecks Arch Chir 1990: 375: 66.
28. Salehi P, Hansen MA, Avila JG et al. Human islet isolation outcomes from pancreata preserved with histidine-tryptophan ketoglutarate versus University of Wisconsin solution. Transplantation 2006: 82: 983.
29. Erhard J, Lange R, Scherer R et al. Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. A prospective, randomized study. Transpl Int 1994: 7: 177.
30. Hatano E, Kiuchi T, Tanaka A et al. Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living-related and cadaveric liver transplantation. Clin Sci (Lond) 1997: 93: 81.
31. Canelo R, Hakim NS, Ringe B. Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation. Int Surg 2003: 88: 145.
32. Avolio AW, Agnes S, Nure E et al. Comparative evaluation of two perfusion solutions for liver preservation and transplantation. Transplant Proc 2006: 38: 1066.
33. Meine MH, Zanotelli ML, Neumann J et al. Randomized clinical assay for hepatic grafts preservation with University of Wisconsin or histidine-tryptophan-ketoglutarate solutions in liver transplantation. Transplant Proc 2006: 38: 1872.
34. Mangus RS, Tector AJ, Agarwal A, Vianna R, Murdock P, Fridell JA. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation. Liver Transpl 2006: 12: 226.
35. Fung JJ, Eghtesad B, Patel-Tom K. Using livers from donation after cardiac death donors - a proposal to protect the true Achilles heel. Liver Transpl 2007: 13: 1633.
36. Welling TH, Heidt DG, Englesbe MJ et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 2008: 14: 73.
37. Chan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transpl 2004: 10: 1415.
38. Moray G, Sevmis S, Karakayali FY, Gorur SK, Haberal M. Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. Transplant Proc 2006: 38: 3572.
39. Testa G, Malago M, Nadalin S et al. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: Results of a prospective study. Liver Transpl 2003: 9: 822.
40. Mangus RS, Tector AJ, Fridell JA, Kazimi M, Hollinger EF, Vianna RM. Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in intestinal and multivisceral transplantation. Transplantation 2008: 86: 298.